Compare APPF & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APPF | CRL |
|---|---|---|
| Founded | 2006 | 1947 |
| Country | United States | United States |
| Employees | N/A | 20100 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.3B |
| IPO Year | 2015 | 1999 |
| Metric | APPF | CRL |
|---|---|---|
| Price | $172.23 | $168.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | ★ $296.11 | $199.64 |
| AVG Volume (30 Days) | 475.9K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.88 | N/A |
| Revenue | $950,822,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $19.58 | $2.51 |
| Revenue Next Year | $16.62 | $4.66 |
| P/E Ratio | $44.39 | ★ N/A |
| Revenue Growth | ★ 19.72 | 10.48 |
| 52 Week Low | $166.36 | $91.86 |
| 52 Week High | $325.90 | $228.88 |
| Indicator | APPF | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 33.60 | 32.93 |
| Support Level | $166.36 | $146.33 |
| Resistance Level | $177.55 | $164.36 |
| Average True Range (ATR) | 7.80 | 10.68 |
| MACD | -0.17 | -3.27 |
| Stochastic Oscillator | 22.15 | 27.56 |
AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.